Faropenem sodium
CAS No. 122547-49-3
Faropenem sodium ( —— )
Catalog No. M21563 CAS No. 122547-49-3
Faropenem sodium is an orally bioavailable penem antibiotic which can efficiently kill Mycobacterium tuberculosis.It treatment of tuberculosis and community-acquired pneumonia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 35 | In Stock |
|
25MG | 64 | In Stock |
|
50MG | 95 | In Stock |
|
100MG | 140 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFaropenem sodium
-
NoteResearch use only not for human use.
-
Brief DescriptionFaropenem sodium is an orally bioavailable penem antibiotic which can efficiently kill Mycobacterium tuberculosis.It treatment of tuberculosis and community-acquired pneumonia.
-
DescriptionFaropenem sodium is an orally bioavailable penem antibiotic which can efficiently kill Mycobacterium tuberculosis.It treatment of tuberculosis and community-acquired pneumonia.
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorBacterial
-
Research Area——
-
IndicationOtitis Media
Chemical Information
-
CAS Number122547-49-3
-
Formula Weight307.3
-
Molecular FormulaC12H14NNaO5S
-
Purity>98% (HPLC)
-
SolubilityDMSO:25 mg/mL (81.35 mM; Need ultrasonic);H2O:100 mg/mL (325.41 mM; Need ultrasonic)
-
SMILES[Na+].[H][C@]12SC([C@H]3CCCO3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C([O-])=O
-
Chemical Namesodium (5R6S)-6-((R)-1-hydroxyethyl)-7-oxo-3-((R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Uchino H Tamai I Yabuuchi H et al. Faropenem Transport across the Renal Epithelial Luminal Membrane via Inorganic Phosphate Transporter Npt1[J]. Antimicrobial Agents & Chemotherapy 2000 44(3):574-577.
molnova catalog
related products
-
Lenampicillin hydroc...
An efficient prodrug of ampicillin with enhanced absorption and decreased side effects.
-
Erythromycin
Erythromycin, an oral macrolide antibiotic produced by Streptomyces erythreus, reversibly binds to the 50S ribosome of bacteria, and inhibits protein synthesis.
-
Deacylketoconazole
Deacylketoconazole is a Ketoconazole derivative and is also an antifungal agent.